$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci

$poci Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003400 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$5.020M	$5.048M	$4.651M
YoY Change	4.72%	8.53%	89.21%
Cost Of Revenue	$3.270M	$3.312M	$2.923M
YoY Change	-2.45%	13.3%	78.21%
Gross Profit	$1.760M	$1.736M	$1.728M
YoY Change	22.11%	0.46%	111.27%
Gross Profit Margin	35.06%	34.39%	37.16%
Selling, General & Admin	$2.040M	$2.023M	$1.574M
YoY Change	24.49%	28.49%	69.66%
% of Gross Profit	115.91%	116.53%	91.1%
Research & Development	$330.0K	$206.4K	$214.9K
YoY Change	41.49%	-3.97%	47.13%
% of Gross Profit	18.75%	11.89%	12.43%
Depreciation & Amortization	$50.00K	$60.00K	$30.19K
YoY Change	-4.49%	98.74%	-10.28%
% of Gross Profit	2.84%	3.46%	1.75%
Operating Expenses	$2.370M	$2.229M	$1.789M
YoY Change	26.61%	24.59%	66.6%
Operating Profit	-$610.0K	-$493.3K	-$61.12K
YoY Change	41.69%	707.05%	-76.13%
Interest Expense	-$50.00K	$48.12K	-$52.78K
YoY Change	-2.67%	-191.18%	7777.61%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$90.00K	-$400.0K	-$113.9K
YoY Change	-133.3%	251.19%	-120.62%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$100.0K	-$398.4K	-$113.9K
YoY Change	-137.13%	249.81%	-120.62%
Net Earnings / Revenue	-1.99%	-7.89%	-2.45%
Basic Earnings Per Share		-$0.07	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.07	-$6.779K
COMMON SHARES
Basic Shares Outstanding	5.641M shares	5.638M shares	5.601M shares
Diluted Shares Outstanding		5.640M shares	5.601M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.930M	$610.0K	$831.6K
YoY Change	383.7%	-26.65%	6.36%
Cash & Equivalents	$2.926M	$612.1K	$831.6K
Short-Term Investments
Other Short-Term Assets	$250.0K	$310.0K	$318.6K
YoY Change	17.12%	-2.68%	141.03%
Inventory	$2.776M	$2.960M	$2.965M
Prepaid Expenses	$249.7K	$307.7K
Receivables	$3.907M	$4.390M	$3.348M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.859M	$8.269M	$7.463M
YoY Change	51.56%	10.8%	69.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$433.5K	$444.6K	$766.8K
YoY Change	-30.91%	-42.02%	11.82%
Goodwill	$8.824M	$8.824M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$9.881M	$9.917M	$9.804M
YoY Change	-3.11%	1.16%	549.73%
TOTAL ASSETS
Total Short-Term Assets	$9.859M	$8.269M	$7.463M
Total Long-Term Assets	$9.881M	$9.917M	$9.804M
Total Assets	$19.74M	$18.19M	$17.27M
YoY Change	18.18%	5.33%	192.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.432M	$2.649M	$2.538M
YoY Change	8.62%	4.38%	147.71%
Accrued Expenses	$1.100M	$1.470M	$907.9K
YoY Change	26.83%	61.91%	40.63%
Deferred Revenue	$1.175M	$1.388M	$1.018M
YoY Change	29.78%	36.29%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$513.3K	$371.4K	$407.8K
YoY Change	39.58%	-8.92%	979.46%
Total Short-Term Liabilities	$5.260M	$6.495M	$5.771M
YoY Change	14.67%	12.54%	173.82%
LONG-TERM LIABILITIES
Long-Term Debt	$2.176M	$1.682M	$2.175M
YoY Change	10.95%	-22.69%	1241.04%
Other Long-Term Liabilities	$190.0K	$230.0K	$792.6K
YoY Change	-82.29%	-70.98%	334.69%
Total Long-Term Liabilities	$2.176M	$1.682M	$2.968M
YoY Change	10.95%	-43.34%	761.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.260M	$6.495M	$5.771M
Total Long-Term Liabilities	$2.176M	$1.682M	$2.968M
Total Liabilities	$7.436M	$8.176M	$8.739M
YoY Change	13.56%	-6.43%	256.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.24M	-$48.14M
YoY Change	0.3%
Common Stock	$60.67K	$56.41K
YoY Change	-64.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.05M	$9.698M	$8.528M
YoY Change
Total Liabilities & Shareholders Equity	$19.74M	$18.19M	$17.27M
YoY Change	18.18%	5.33%	192.36%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$100.0K	-$398.4K	-$113.9K
YoY Change	-137.13%	249.81%	-120.62%
Depreciation, Depletion And Amortization	$50.00K	$60.00K	$30.19K
YoY Change	-4.49%	98.74%	-10.28%
Cash From Operating Activities	-$610.0K	$510.0K	-$164.8K
YoY Change	1042.32%	-409.45%	-216.05%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$10.00K	-$44.57K
YoY Change	-100.0%	-122.44%	46.42%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$166.7K
YoY Change	-100.0%	-100.0%	0.0%
Cash From Investing Activities	$0.00	-$10.00K	-$211.2K
YoY Change	-100.0%	-95.27%	7.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$46.64K
YoY Change			64.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.920M	-270.0K	-55.58K
YoY Change	-1185.42%	385.79%	-369.02%
NET CHANGE
Cash From Operating Activities	-610.0K	510.0K	-164.8K
Cash From Investing Activities	0.000	-10.00K	-211.2K
Cash From Financing Activities	2.920M	-270.0K	-55.58K
Net Change In Cash	2.310M	230.0K	-431.6K
YoY Change	-1122.89%	-153.29%	1153.98%
FREE CASH FLOW
Cash From Operating Activities	-$610.0K	$510.0K	-$164.8K
Capital Expenditures	$0.00	$10.00K	-$44.57K
Free Cash Flow	-$610.0K	$500.0K	-$120.2K
YoY Change	-3757.07%	-515.83%	-169.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000867840
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense		usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-10647
	dei	Entity Registrant Name EntityRegistrantName	PRECISION OPTICS CORPORATION, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2795294
	dei	Entity Address Address Line1 EntityAddressAddressLine1	22 East Broadway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardner
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01440-3338
	dei	City Area Code CityAreaCode	(978)
	dei	Local Phone Number LocalPhoneNumber	630-1800
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	POCI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5640995	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	612095	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605749	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	74593	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44135	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4389907	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2663872	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	2959732	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3079938	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	307663	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	213448	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8269397	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6563007	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3225483	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3215412	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	794894	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	786112	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	233547	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	219999	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4253924	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4221523	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3809303	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3651843	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	444621	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	569680	usd
CY2023Q1	us-gaap	Assets Assets	18186643	usd
CY2022Q2	us-gaap	Assets Assets	16704020	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	42397	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	399007	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517725	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	249408	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	229398	usd
CY2023Q1	us-gaap	Goodwill Goodwill	8824210	usd
CY2022Q2	us-gaap	Goodwill Goodwill	8824210	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	40705	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	371429	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	367714	usd
CY2023Q1	POCI	Acquisition Earn Out Liability Current AcquisitionEarnOutLiabilityCurrent	571838	usd
CY2022Q2	POCI	Acquisition Earn Out Liability Current AcquisitionEarnOutLiabilityCurrent	166667	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2649248	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2239175	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1387806	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1305678	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	716702	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	166316	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	150565	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6494712	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4586641	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	79701	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	111691	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1681642	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1961141	usd
CY2023Q1	POCI	Acquisition Earn Out Liability Noncurrent AcquisitionEarnOutLiabilityNoncurrent	0	usd
CY2022Q2	POCI	Acquisition Earn Out Liability Noncurrent AcquisitionEarnOutLiabilityNoncurrent	705892	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	232691	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	367160	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5640995	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5640995	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5638302	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5638302	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	56410	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	56383	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57784369	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57009506	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48142882	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48094394	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9697897	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8971495	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18186643	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16704020	usd
CY2023Q1	us-gaap	Revenues Revenues	5048065	usd
CY2022Q1	us-gaap	Revenues Revenues	4651352	usd
	us-gaap	Revenues Revenues	16020327	usd
	us-gaap	Revenues Revenues	10884737	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3311967	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2923143	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10045316	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7397914	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1736098	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1728209	usd
	us-gaap	Gross Profit GrossProfit	5975011	usd
	us-gaap	Gross Profit GrossProfit	3486823	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	206375	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	214898	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	660518	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	433248	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2022991	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1574432	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5338498	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3974824	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	172174	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2229366	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1789330	usd
	us-gaap	Operating Expenses OperatingExpenses	5999016	usd
	us-gaap	Operating Expenses OperatingExpenses	4580246	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-493268	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-61121	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24005	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1093423	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	48124	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	52778	usd
	us-gaap	Interest Expense InterestExpense	167443	usd
	us-gaap	Interest Expense InterestExpense	104290	usd
CY2023Q1	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	142960	usd
CY2022Q1	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	0	usd
	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	142960	usd
	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-398432	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-113899	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1197713	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5640473	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5640473	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5600953	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5600953	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5639015	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5639015	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5181896	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5181896	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8971495	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	74990	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-158724	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8887761	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	244786	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	508668	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641215	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	450014	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5100	usd
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	307	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-398432	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9697897	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	3431127	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160071	usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	10000	usd
CY2021Q3	POCI	Stock Issued During Period Subscribed Value New Issues StockIssuedDuringPeriodSubscribedValueNewIssues	1020000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-576801	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	4034397	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	330451	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	470000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4825000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16650	usd
CY2021Q4	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	478	shares
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-507013	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9189485	usd
CY2022Q1	POCI	Correction Of Error In Valuation Of Stock Issued In Business Acquisition CorrectionOfErrorInValuationOfStockIssuedInBusinessAcquisition	-825000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	231115	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	46640	usd
CY2022Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	32018	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-113899	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8528341	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1197713	usd
	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	142960	usd
	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	-0	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	157460	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	173887	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	769790	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	741637	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8906	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1726035	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	791959	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-120206	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	623817	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-0	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-84210	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	94215	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	85791	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	410073	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1118149	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	482693	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-258487	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	588976	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-40083	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	526406	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-879967	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20010	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23098	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32401	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59562	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	-0	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	421729	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52411	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-504389	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	30298	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	28546	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	275784	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	154453	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000	usd
	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	166667	usd
	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	-0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1500000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5100	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	63290	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-467649	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1354291	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6346	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-30065	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	605749	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	861650	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	612095	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	831585	usd
	POCI	Offering Costs Included In Accrued Compensation And Other OfferingCostsIncludedInAccruedCompensationAndOther	0	usd
	POCI	Offering Costs Included In Accrued Compensation And Other OfferingCostsIncludedInAccruedCompensationAndOther	10000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
	POCI	Acquisition Of Business Financed With Longterm Debt AcquisitionOfBusinessFinancedWithLongtermDebt	0	usd
	POCI	Acquisition Of Business Financed With Longterm Debt AcquisitionOfBusinessFinancedWithLongtermDebt	2600000	usd
	us-gaap	Reclassifications Reclassifications	<p id="xdx_843_eus-gaap--Reclassifications_ztAK0f7LtyRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zAVNXh5Hue2k">Reclassifications</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to conform the prior period consolidated financial statements to the current period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one-for-three
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16915089	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5638302	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zPm9Dm2xyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86C_z32p2EpMwNki">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-398432	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-113899	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-48488	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1197713	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5640473	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5640473	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5600953	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5600953	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5639015	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5639015	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5181896	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5181896	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1058630	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1058630	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	939166	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	939166	shares
CY2022Q3	us-gaap	Revenues Revenues	5085301	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3445860	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1639441	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-101802	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-158724	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q4	us-gaap	Revenues Revenues	5886961	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	3287489	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	2599472	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	571065	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	508668	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	750000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	750000	usd
CY2023Q1	POCI	Business Combination Adjusted Contingent Consideration Liability BusinessCombinationAdjustedContingentConsiderationLiability	600000	usd
	us-gaap	Other Income OtherIncome	150000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	600000	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5048065	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4651352	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	16020327	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	12329074	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-398432	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-113899	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-48488	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1140418	usd
CY2023Q1	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.07
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	231115	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	769790	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	721637	usd
CY2023Q1	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.07
CY2022Q1	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.02
CY2022Q1	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.02
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.01
	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.01
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.20
	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.20
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1402292	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1414996	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	393078	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	518251	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1164362	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1146691	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	2959732	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3079938	usd
CY2023Q1	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0950	pure
CY2023Q1	us-gaap	Termination Loans TerminationLoans	2073808	usd
CY2023Q1	POCI	Current Maturities CurrentMaturities	371429	usd
CY2023Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	2789	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	20737	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1681642	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	92856	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	371429	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	371429	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	371429	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	371429	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	495236	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2073808	usd
CY2023Q1	POCI	Net Book Value Of Fixed Assets Under Capital Lease Obligations NetBookValueOfFixedAssetsUnderCapitalLeaseObligations	114695	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	101928	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	399007	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166316	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	232691	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	450014	usd
CY2023Q1	us-gaap	Revenues Revenues	5048065	usd
CY2022Q1	us-gaap	Revenues Revenues	4651352	usd
	us-gaap	Revenues Revenues	16020327	usd
	us-gaap	Revenues Revenues	10884737	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	794981	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1137470	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	450084	usd
CY2023Q1	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
CY2022Q1	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	826679	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1020669	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	774316	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1917775	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1388700	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-427844	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-893511	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1435082	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1647188	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1387806	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1018275	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1387806	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1018275	usd

Files In Submission

Name	View Source	Status
poci-20230331_cal.xml	Edgar Link	unprocessable
poci-20230331_pre.xml	Edgar Link	unprocessable
0001683168-23-003400-index-headers.html	Edgar Link	pending
0001683168-23-003400-index.html	Edgar Link	pending
0001683168-23-003400.txt	Edgar Link	pending
0001683168-23-003400-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
poci-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
poci-20230331_def.xml	Edgar Link	unprocessable
poci-20230331_lab.xml	Edgar Link	unprocessable
poci_ex3101.htm	Edgar Link	pending
poci_ex3102.htm	Edgar Link	pending
poci_ex3201.htm	Edgar Link	pending
poci_i10q-33123.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
poci_i10q-33123_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci

2023 Q2 Form 10-Q Financial Statement

#000168316823003400 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI PRECISION OPTICS CORPORATION, INC. Stock $poci

2023 Q2 Form 10-Q Financial Statement

#000168316823003400 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci